Clinical Trials Logo

Filter by:
NCT ID: NCT00298324 Terminated - Clinical trials for Graft vs Host Disease

Myfortic - Treatment for Extensive cGvHD

Start date: September 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the response to treatment for extensive chronic Graft versus Host Disease (cGvHD)is improved with the addition of myfortic alongside cyclosporine A and prednisone, compared to the reference treatment of cyclosporine A and prednisone alone.

NCT ID: NCT00297895 Completed - Melanoma Clinical Trials

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Start date: September 30, 2004
Phase: N/A
Study type: Interventional

Subjects must be diagnosed with melanoma. All subjects receive sentinel lymphadenectomy. If the subject is sentinel node positive and meets study requirements, the subject is randomized to receive either (1) completion lymphadenectomy (2) observation with nodal ultrasound. Subjects are then followed for 10 years.

NCT ID: NCT00297661 Completed - Clinical trials for Coronary Heart Disease

Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization

Start date: April 2003
Phase: Phase 4
Study type: Interventional

Context: Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk of restenosis. It is unclear whether there are differences in safety and efficacy between the two types of drug-eluting stents. Objective: To determine differences in safety and efficacy between sirolimus and paclitaxel eluting stents.

NCT ID: NCT00297232 Terminated - Clinical trials for Relapsing-Remitting Multiple Sclerosis

Natalizumab (Tysabri) Re-Initiation of Dosing

STRATA
Start date: March 2006
Phase: Phase 3
Study type: Interventional

The primary objectives for the initial treatment period of this study are to further evaluate the safety of natalizumab monotherapy by evaluating the risk of hypersensitivity reactions and immunogenicity following re-exposure to natalizumab and confirming the safety of switching from interferon (IFN), glatiramer acetate, or other multiple sclerosis (MS) therapies to natalizumab. The primary objective for the long-term treatment period of this study is to evaluate the long-term impact of natalizumab monotherapy on the progression of disability measured by Expanded Disability Status Scale (EDSS) changes over time.

NCT ID: NCT00297193 Terminated - Crohn Disease Clinical Trials

ASTIC Autologous Stem Cell Transplantation for Crohn's Disease

Start date: June 2006
Phase: Phase 3
Study type: Interventional

Transplant study for patients with relapsing Crohn's disease demonstrating clear intolerance or toxicity to conventional treatment. The purpose of this study is to determine whether there is a potential clinical benefit of hematopoietic stem cell mobilisation followed by high dose immuno-ablation and autologous stem cell transplantation versus hematopoietic stem cell mobilisation only followed by best clinical practice.

NCT ID: NCT00296907 Completed - Cancer Clinical Trials

Psychological Interventions in Siblings of Children With Cancer

Start date: April 2006
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effectiveness of a two-session brief psychological intervention in siblings of pediatric cancer patients with regard to behavior problems and depression.

NCT ID: NCT00296855 Completed - Clinical trials for Peripheral Vascular Diseases

Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

Start date: February 2006
Phase: Phase 3
Study type: Interventional

The particular aim of this study is the comparison of the diagnostic results of MRA images upon application of Vasovist (gadofosveset), a contrast agent not yet available on the market, with the MRA images upon application of a conventional extracellular contrast agent. A catheter angiography, which will be performed as a routine diagnostic procedure for vascular diseases, will serve as an evaluation standard.

NCT ID: NCT00296842 Completed - Injury Clinical Trials

Prevention of Posttraumatic Stress Symptoms and Behavioral Problems in Children After Road Traffic Accidents: a Randomized Controlled Trial

Start date: November 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to study the effectiveness of an early psychological intervention 7-10 days after a road traffic accident on posttraumatic stress and behavior of children and adolescents

NCT ID: NCT00296309 Completed - Clinical trials for Kidney Transplantation

Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.

SENIOR
Start date: October 2004
Phase: Phase 3
Study type: Interventional

Primary objective of this study is to compare the renal function as well as the incidence of renal dysfunction, the incidence of death, graft loss and acute rejection. Secondary Objective is to compare the efficacy and safety profiles of the two regimens in elderly renal transplanted patients.

NCT ID: NCT00296218 Completed - Hypertension Clinical Trials

ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

Start date: February 2006
Phase: Phase 3
Study type: Interventional

Primary Objective - The main objective of this study is to assess if a two-month regimen of irbesartan in patients hospitalized for acute coronary syndrome without ST segment elevation can reduce inflammation markers (ie hsCRP), in comparison to a similar regimen of enalapril. Secondary Objectives - To compare both regimens on several other biological parameters which have demonstrated their relevance and their predictive clinical value (ie BNP, microalbuminuria, troponin I …) in this patient population. - To compare on the above parameters the early initiation of treatment versus the initiation of treatment at hospital discharge.